This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John F. Beary III, MD
Pharmaceutical Research and Manufacturers of America Washington, DC

JAMA. 1994;272(16):1254.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Nahata suggests that honoraria received in support of writing review articles be disclosed as part of the biomedical publishing process.

The proposal is consistent with the general practice of disclosure so that readers can effectively evaluate information. Such disclosure is consistent with the promotional practice guidelines adopted by Pharmaceutical Research and Manufacturers of America member companies.

We have commented on an abuse of the system, in which prominent physicians are paid to allow their names to be added to reviews entirely written by ghost authors hired by pharmaceutical companies.¹ Since those whose names appear are not authors, and those who did the writing remain anonymous, none of the criteria for authorship are satisfied, and the principle that named authors are entirely responsible for published articles is flouted.²—ED. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?